TLR4 and hypertensive disorder: Finally, in a model of aldosterone-induced hypertension, TLR4 activation was associated with the downstream release of several inflammatory mediators leading to tubulointerstitial damage and fibrosis, whereas anti-TLR4 treatment significantly reversed those deleterious effects [36].